Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
89Bio Inc. currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners but are concentrated within 1 distinct art unit. This concentration suggests that while the portfolio involves different reviewers, the subject matter remains within a regulatory group at the patent office. The alignment with a single art unit can often lead to consistent examination outcomes as the examiners likely share similar internal guidelines and technical expertise.
The busiest examiner for this portfolio is CHO, DAVID H, who is responsible for 1 pending office action. Because the total number of pending actions is distributed among distinct examiners, the workload is shared. Practitioners should note that the single art unit designation indicates a consistent examination environment despite the involvement of different individuals. This structure allows the applicant to potentially encounter similar prior art citations or legal arguments across their pending matters, given the shared technical oversight of the unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHO, DAVID H | 1 | 31.9% | +67.0% |
| KOMATSU, LI N | 1 | 59.8% | +71.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18740787 | CHEMICAL SYNTHESIS OF CYTIDINE-5'-MONOPHOSPHO-N-GLYCYL-SIALIC ACID | CHO, DAVID H | — |
| 17793953 | METHODS FOR PROMOTING WEIGHT LOSS | KOMATSU, LI N | — |
| Art Unit | Apps |
|---|---|
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18740787 | CHEMICAL SYNTHESIS OF CYTIDINE-5'-MONOPHOSPHO-N-GLYCYL-SIALIC ACID | CHO, DAVID H | — | §112 | Non-Final OA | — | Pending | Jun 12, 2024 |
| 17793953 | METHODS FOR PROMOTING WEIGHT LOSS | KOMATSU, LI N | 1658 | §103§112DP | Non-Final OA | — | Pending | Jul 20, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial